The Marine Biotechnology Market is valued at USD 8.3 Billion in 2026.
The Marine Biotechnology Market is projected to grow at a 8% CAGR through 2033.
The Marine Biotechnology Market growth is driven by the rising demand for biofuels and sustainable energy solutions, increasing use of marine-derived ingredients in cosmetics and pharmaceuticals, and expanding research in aquaculture and drug discovery.
Europe is the dominant region in the Marine Biotechnology Market.
BASF SE, Lonza Group AG, Aker BioMarine ASA, PharmaMar S.A., and Cyanotech Corporation are some leading industry players in the Marine Biotechnology Market.